Melissa McCracken, PhD - Profile and Investment Details

Investor Profile

Melissa McCracken, PhD is a Venture Capital, Private Equity Firm, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Black Diamond Therapeutics, Blueprint Medicines, TRACON Pharmaceuticals, Jounce Therapeutics, Peloton Therapeutics, Arvinas, Cullinan Oncology, Silverback Therapeutics, Sunesis Pharmaceuticals, MolecularMD, MOMA Therapeutics, Scorpion Therapeutics, PMV Pharmaceuticals, Cleave Therapeutics, Vividion Therapeutics, Tyra Biosciences, Turning Point Therapeutics, ImaginAb, Neon Therapeutics, Telormedix, Ganymed Pharmaceuticals, Circle Pharma, EQRx, Kronos Bio, A2 Biotherapeutics, TetraLogic Pharmaceuticals, Kinnate Biopharma, Arrakis Therapeutics, Revolution Medicines, Kura Oncology, IconOVir Bio, IDEAYA Biosciences, Autolus, C4 Therapeutics, Agensys. Over time, Melissa McCracken, PhD has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Melissa McCracken, PhD is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Information Technology (IT), Biotech, Medical Device, Healthcare, Biotechnology, Health and Hospital Services, Health IT, Travel, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Melissa McCracken, PhD, as their portfolio suggests a familiarity and interest in this area.

Understanding Melissa McCracken, PhD’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.